{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:37:07Z","timestamp":1790735827654,"version":"4.1.0"},"reference-count":32,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2010,11,23]],"date-time":"2010-11-23T00:00:00Z","timestamp":1290470400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[2011,1,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We examined trends in the incidence and mortality, and described the survival of patients with penile squamous cell carcinoma in the Netherlands between 1989 and 2006. On the basis of nationwide population\u2010based data, 3\u2010year moving average European age\u2010standardized incidence and 10\u2010year relative survival estimates were calculated. Penile squamous cell carcinomas were categorized according to stage grouping based on the TNM classification. In the 17\u2010year study period, 2000 primary penile cancers were diagnosed in the Netherlands of which 1883 (94%) were squamous cell carcinomas. Median age at diagnosis was 68 years. The majority of patients (57%) were diagnosed with localized tumors (Stage 0 or I). The percentage of missing disease characteristics increased with increasing age. The 3\u2010year moving average incidence rate of patients with penile squamous cell carcinoma increased significantly from 1.4 per 100,000 person\u2010years in 1989 to 1.5 in 2006 with an estimated annual percentage of change of 1.3%. Ten\u2010year relative survival of patients according to the different stage groups was 93% for Stage 0, 89% for Stage I, 81% for Stage II, the 9\u2010year survival was 50% for patients with Stage III disease and a 2\u2010year survival of 21% for patients was found for Stage IV disease. Our study shows that the incidence rate of penile squamous cell carcinoma in the Netherlands has increased slightly, especially the incidence of carcinomas <jats:italic>in situ<\/jats:italic>. Patients with Stage III and IV tumors have poor survival.<\/jats:p>","DOI":"10.1002\/ijc.25355","type":"journal-article","created":{"date-parts":[[2010,3,25]],"date-time":"2010-03-25T15:22:28Z","timestamp":1269530548000},"page":"426-432","source":"Crossref","is-referenced-by-count":66,"title":["Incidence trends and survival of penile squamous cell carcinoma in the Netherlands"],"prefix":"10.1002","volume":"128","author":[{"given":"Niels M.","family":"Graafland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob H.A.","family":"Verhoeven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan\u2010Willem W.","family":"Coebergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Horenblas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,11,23]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23743"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008469-199202000-00008"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365590050509913"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.1.19"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)62506-0"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.3182"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-008-0302-z"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.105.3.e36"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10749"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)35221-7"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/jso.20980"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2006.08.029"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-07-0221"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20519"},{"key":"e_1_2_5_16_2","volume-title":"International classification of disease for oncology","author":"World Health Organization","year":"2003"},{"key":"e_1_2_5_17_2","volume-title":"TNM classification of malignant tumours","author":"Sobin L","year":"2002"},{"key":"e_1_2_5_18_2","unstructured":"Website Netherlands Cancer Registration. Available at:http:\/\/www.ikcnet.nl\/uploaded\/FILES\/Landelijk\/cijfers\/incidentie%202006\/B2_EN.xls 2009. Accessed on 23 November 2009."},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0010-468X(85)90011-X"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.311.7018.1471"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-004-1324-5"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.04.028"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000154565.37397.4d"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)66863-0"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)65169-5"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2006.06296.x"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.6870"},{"key":"e_1_2_5_29_2","first-page":"251","volume-title":"SEER survival monograph: cancer survival among adults: U.S. SEER program, 1988\u20132001, patient and tumor characteristics","author":"Young JL","year":"2007"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.1993.tb16273.x"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2006.10.060"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2008.07.014"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2007.02.006"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.25355","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.25355","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T06:32:36Z","timestamp":1697437956000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.25355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,23]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,1,15]]}},"alternative-id":["10.1002\/ijc.25355"],"URL":"https:\/\/doi.org\/10.1002\/ijc.25355","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,23]]}}}